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Abstract
Background: Although dental implant therapy is considered a predictable treatment modality
with reported high survival and success rates, biological complications do occur, and a number
of risk factors have been involved. Tobacco smoking is related to many health risks affecting
general & oral health.
Objectives: The aim of this systematic review and meta-analysis is to test the null hypothesis of
no difference in dental implant failure rates and marginal bone loss between smokers and nonsmokers with regards to follow-up time.
Search methods: An extensive electronic search was performed in PubMed, Scopus and
EBSCOhost Dentistry and Oral Sciences source to identify relevant articles published up to June
2019. The eligibility criteria included randomized and non-randomized clinical trials &
prospective & retrospective observational studies. After a thorough selection process, 23 papers
were included. The meta-analysis was expressed in terms of the odds ratio (OR) or standardized
mean difference (SMD) with a conﬁdence interval (CI) of 95% and the level of statistical
signiﬁcance was set at P < 0.05.
Results: There was a statistically signiﬁcant difference in marginal bone loss favoring the nonsmoking group with a SMD of 1.07 (95% CI 0.67–1.48), demonstrating a statistically signiﬁcant
difference in favor of non-smokers (P<0.00001). A subgroup analysis in smokers revealed a
statistically significant increase in marginal bone loss in the maxillary implants compared to the
mandible (P = 0.008) with a SMD of 1.39 (95% CI 0.35–2.42) although with a high level of
heterogeneity (I2 = 97%; P = 0.0001). A statistically signiﬁcant difference (P < 0.00001) in
implant failure rate in favor of the non-smoking group was also observed, with OR of 2.24 (95%
CI 1.90–2.64). Moreover, the subgroup analysis for follow-up time revealed a signiﬁcant
increase in implant failure proportional to the increase in follow-up time (P = 0.05), but with
considerable heterogeneity (I2=74.5%).
Author’s conclusion: Based on the results of this review, the null hypothesis is rejected, and that
is in agreement with other reports in the literature. Therefore, the clinical recommendation for a
period of abstinence from smoking that at least covers the pre-surgical evaluation & initial
therapy, definite implant treatment & immediate post-op phases remains to be very relevant.
Keywords: edentulous, partially edentulous, smoking, tobacco use, dental implants, bone
resorption, marginal bone loss, failure rate, cumulative survival rate.
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Review of pertinent literature
Methods of evidence-based dental practice was introduced to optimize the decision-making
processes in diagnosis and treatment planning, and for comprehensive patient information in
preparation of diagnostic and therapeutic interventions, particularly before elective procedures.
Outcome anticipation is an important aspect of risk management in contemporary implant
dentistry. Recognizing the factors that may potentially place the patient receiving dental
implant(s) at a higher risk of implant failure or other adverse conditions allows the practitioner to
make informed decisions and reﬁne the treatment approach to optimize the results and improve
the predictability of successful therapy.59 As in other topics, RCTs are one of the most reliable
sources of information for clinical practice and therefore are the studies preferred for the
elaboration of longitudinal studies in implant dentistry.73 However, the inclusion of longitudinal
observational studies, with high number of participants can potentially increase the amount of
viable data. The Early longitudinal studies evaluating osseointegrated dental implants showed
satisfactory results.65,66 Currently, with more than 40 years of scientiﬁc evidence, the clinical use
of dental implants has been increasing day by day. Nevertheless, few studies have examined
follow-up periods for ten years or longer, which is important to enable us to understand the
biological aspects of dental implant therapy.136 Implant-supported prostheses have been shown to
have successful long-term outcomes.19,31,32,83, 91,94 However, numerous local and systemic factors
have been hypothesized to affect implant success to various degrees.59,69,160 Such factors include
but are not limited to implant insertion in type III and IV bone qualities,50 reduced initial stability
of the implant, particularly in cases of immediate loading protocol, implant placement in
posterior maxilla, radiation therapy sites, drug and alcohol intake, and tobacco smoking. When a
cause-effect relationship is being investigated, an accurate definition of the potential cause is
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imperative. This is particularly important when the effect is expected to be frequency and dose
dependent. In the medical literature, smoking was established to cause a dose-dependent effect
on the extent of bone loss and the risk of fracture in long bones.167 Surprisingly, however,
smaller doses of nicotine have been found to stimulate osteoblastic growth.98 Wide variations in
the definition of smoking are encountered in the dental literature in terms of smoking duration,
number of cigarettes consumed daily, and categorization of previous smokers, and these
variations prevent a detailed analysis of the predictability of measure outcomes. Different patient
and implant-related confounding factors have been shown to impact the clinical outcomes
associated with dental implants, but these factors are not always considered in the included
studies. Many studies investigated the correlation between tobacco smoking and adverse
implant-related outcomes, some align with the hypothesis that tobacco smoking increases
implant failure rate, but others does not reach the same conclusion.6,49,120,159 Currently, no
consensus has been reached, and no evidence-based guidelines have been generated to help
clinicians make informed clinical decisions in utilizing dental implant treatment in tobacco
smokers. These shortcomings may be attributed to several factors, like the variability in the
design, quality and findings of studies conducted. The considerable heterogeneity among the
studies has made direct comparison across studies a difficult task. Therefore, there is a limited
number of recent systematic reviews comparing dental implant complications in smokers to nonsmokers. Peri-implant mucositis is the most common biological complication associated with
dental implants.73,144 It is characterized by a reversible inﬂammatory process, demonstrating a
color change and redness and bleeding of the peri-implant mucosa, without presenting signs of
bone resorption. Probing of the peri-implant sulcus and identifying signs such as the presence of
bleeding or suppuration is important for thorough diagnosis of implant health,173 particularly
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peri-implant mucositis. Clinically, peri-implant probing depth is inﬂuenced by a number of
factors, including the depth of implant placement, the level of peri-implant marginal bone, periimplant soft tissue phenotype and thickness, type of the prosthetic abutment, emergence proﬁle
of the prosthetic restoration, the region in which the implant was placed.114 Probing depths of
>=5 mm must be investigated, as they may be indicative of peri-implant disease. However, periimplant probing depths were either unreported or reported with wide variations with regard to the
exact probing depth value in millimeters or the numbers of sites probed per implant. Therefore,
the author elected not to select peri-implant probing depth as an outcome variable in this review.
Ever since the ﬁrst longitudinal studies were conducted to evaluate the clinical performance of
implants,65,66 various authors have proposed different criteria for classifying implant health and
success. Nonetheless, up to the current time, no standardization for this classiﬁcation has been
made in the literature and that leads to considerable difﬁculty in the interpretation and
comparison of data among the available studies. Due to the differences in criteria adopted by
different authors, it is not always possible to arrive at an absolute mean value for the success
rates in systematic reviews. However, in two systematic reviews by Needleman et al (2012)130
and Papaspyridakos et al (2012)134 evaluating the success criteria for implants, the criteria of
Albrektsson et al. (1986)68 were related in around 33.3% (n = 78) and 31.7% (n = 41) of the
studies included, respectively. This demonstrates that these remain to be the most widely
accepted criteria at the present time. In longitudinal studies on osseointegrated dental implants,
the terms ‘survival’ and ‘success’ are routinely used. However, these terms continue to generate
confusion regarding their actual meanings154 and are frequently used incorrectly. Knowledge and
standardization of these terms is necessary to facilitate communication, comparison, and
thorough understanding among dental professionals.48,73,153,158 Studies evaluating success rates in
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implant dentistry are complex because of the large number of confounding variables, such as
surgical techniques, materials used, and follow-up period. In addition, several criteria have been
proposed for the deﬁnition of success48,62,68,109,143,147,153,172 and the absence of international
standardization makes it rather difficult to compare studies.130,153 While other authors have
argued that a period of 5 years may still be too short to enable reliable information to be
obtained,107 a minimum of 5 years of follow-up is necessary130,137 to properly analyze survival
and success rates of dental implants. The majority of longitudinal studies evaluated only the
survival rate of dental implants, as a quantitative analysis, potentially underestimating the
importance of the data with reference to the overall health and quality of the placed implants.
The most probable reason for the preference for survival studies appears to be related to easier
methodology for that analysis;153 i.e. the measurement for statistical analysis is done only by
counting the implants remaining in situ. Conversely, evaluating dental implant success involves
analysis of more complex parameters and criteria and is more directly associated with the health
and quality of the implants. Consequently, the statistical differences between the survival and
success rates are typically signiﬁcant. Smoking has been shown to be a primary risk factor for
general health and responsible for many serious diseases, as for 90% of all lung cancers, 70% of
chronic lung diseases, 80% of myocardial infarctions before the age of 50, and 30% of chronic
ischemic heart diseases and strokes.51,52,53 There are an estimated 1.3 billion smokers around the
world, and 4.9 million people die from tobacco smoking-related diseases every year (WHO).174
Besides the general role healthcare professionals play in tobacco smoking cessation and
prevention, certain aspects pertaining to modern dental implant practice should be considered in
tobacco smokers for thorough patient evaluation before oral surgical procedures and implant
treatment planning. While the smoking cessation and sustained abstinence well before oral
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surgical procedures should be the ultimate goal, nicotine dependence has proven to be a chronic
relapsing disorder and is usually characterized by multiple failed quitting attempts.129
Nevertheless, a number of studies have suggested that adjunctive measures can possibly
minimize the negative effects of tobacco smoking on dental implant survival rates.70,77
Abstinence from smoking for one week before and eight weeks post implant placement has been
reported to improve the success rate associated with the Branemark implants.70 Opting for a twostage placement and delayed loading protocol with may minimize the accumulation of bacterial
biofilms and the diffusion of several of the nearly 4000 chemicals contained in cigarette
smoke.35,162 Placement of dental implant in special populations like tobacco smokers requires
consideration of the potential beneﬁts to be gained from the treatment and possible adverse
effects. To better appreciate this potential, properly conducted, high-quality systematic reviews
and meta-analysis, whenever possible, comparing the survival rate of dental implants,
postoperative infection, and peri-implant marginal bone loss (MBL) between smokers and nonsmokers are essential to critically summarize the current knowledge and synthesize evidence.
Thorough patient information not only about the planned treatment approach and the expected
outcomes, but also about risks and risk factors are necessary to support the patient’s decision
making before dental implant therapy.155 Moreover, smoking cessation advice, given in
conjunction with dental health information may have a marked effect on smokers’ attitude
toward their habit and provide a powerful incentive to reduce or even quit smoking.125 When
placing dental implants in smokers, the peri-operative use of antibiotics96 as well as additional
local potential preventive measures, like using ﬂat instead of high cover screws, should be
considered in an attempt to prevent postoperative complications during the healing period.18
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Recombinant human parathormone (PTH 1-34), which is an anabolic agent approved for the
treatment of patients with osteoporosis that stimulates osteoblast function,92 has been reported to
increase bone volume around implants in the presence of cigarette smoke in animals.119 It is
strongly suggested that the direct exposure of the peri-implant tissues to tobacco smoke products
is the main factor causing an increase in dental implant failure rate in smokers compared to nonsmokers.104 The increased risk of post-surgical wound healing complications105,126,127,146 as well
as the risk of peri-implant marginal bone loss and increased implant failure rates 10,116,121 must be
emphasized. Delayed wound healing has to be anticipated due to deficient collagen synthesis and
production,106 reduced peripheral blood circulation and capillary bed perfusion115 and
compromised polymorpho-nuclear leucocytes and macrophages functions.110,124 Furthermore,
tobacco smoking was indicated as a signiﬁcant subject-based risk factor for periodontitis in
literature reviews.132,139 Although not entirely understood, the long-term chronic effect of
smoking on periodontitis was found to be due to impairment of periodontal tissues vasculature
through vasoconstrictive effects at the end-arterial gingival vessels,54 multiple function
deficiencies of fibroblasts and neutrophils and reduced inﬂammatory response.132 Therefore, a
regular and strict recall of smoking patients undergoing implant treatment is important for early
detection of implant complications. The carbon monoxide generated during combustion of
tobacco smoking lowers the oxygen tension in tissues by displacing the oxygen from
hemoglobin.117 Nicotine, which has been found in high concentrations in saliva101,103 and
crevicular fluid84 of smokers has been reported to have a negative impact on bone regenerative
capacity.71,161 Furthermore, polymorphonuclear neutrophils viability, opsonization &
phagocytosis are significantly reduced in smokers compared to non-smokers.110 Nicotine is the
most significant constituent among more than 4000 potentially harmful substances in tobacco
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products. It is the principal chemical component that causes tobacco addiction, appears to
mediate the vasoconstrictive effects of tobacco smoking, and involved in the pathogenesis of
many diseases.80 The exact mechanism by which tobacco smoke affects the osseointegration
process remains to be unclear. However, several chemicals found in tobacco smoke have been
shown to reduce the vascularity of the peri-implant tissues, and so may compromise the bone
healing process.132 Approximately 3 mg of nicotine and 20–30 mL of carbon monoxide is
inhaled for each cigarette smoked.151 Nicotine has been related to increased platelet aggregation
and interference with the function of fibroblasts, osteoblasts, red blood cells and
macrophages.55,81,102,164,169 In addition, carbon monoxide converts hemoglobin into
carboxyhemoglobin rather than oxyhemoglobin due to its 200-fold greater affinity for
hemoglobin than oxygen. The formation of carboxyhemoglobin decreases oxygen transportation,
resulting in reduced tissue oxygenation and hypoxia.72,106,117,131,140 Although tobacco smoking is
widely accepted as a risk factor for oral health in general,54 smoking was considered a risk factor
for implant treatment since the ﬁrst publication on this topic by Bain & Moy (1993).3
Nevertheless, the impact of consideration of the patient’s status as a smoker or non-smoker in
dental implant treatment planning seems to be uncontroversial, but indistinct. In 1999, a national
survey questionnaire to National Health Service (NHS) consultants evaluating their attitudes
regarding medical and oral health-related factors considered in patient selection and treatment
planning for dental implant placement revealed that, among others, tobacco smoking was one of
the most important factors contraindicating dental implant therapy.75 Another survey among
Finnish dentists to evaluate the relationship of various patient characteristics or possible
contraindications for dental implant therapy revealed that more dentists practicing in the public
or private sectors recommended implant therapy compared to staff of dental schools in case of
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smoking patients. Older dentists (40–49 years) were found to be more in favor of implant
treatment in smoking patients than younger dentists (30–39 years).99 Therefore, validation of
smoking as a risk factor in treatment decisions may differ among dentists. This impression seems
to be conﬁrmed by different attempts made to quantify the number of cigarettes smoked per day
in different studies. Human and animal studies have showed the deleterious effects of tobacco
smoking on the health of oral tissues. Animal studies86,123 have demonstrated that nicotine
inhibits gene expression of several enzymes that play an important role in the regulation of
osteoblast proliferation, differentiation and apoptosis, subsequently affecting bone formation and
remodeling. Furthermore, it was shown that exposure to nicotine has a direct effect on blood
vessels, producing vasoconstriction which decreases blood perfusion and causes low oxygen and
local ischemia.122,166 In addition to delivering oxygen and nutrients to tissues, blood circulation
plays an active role in bone formation and remodeling by mediating the interactions between
different bone and vascular cells at different regulatory levels.93 In a clinical study (AlBandar et
al. 2000),67 tobacco smokers had a higher prevalence of moderate and severe periodontal disease
with increased attachment loss and gingival recession compared to non-smokers, indicating
worse periodontal conditions in the smokers’ group. Furthermore, smokers had more missing
teeth than non-smokers. Several review articles identiﬁed within this literature search conﬁrmed
that smoking is one of the factors related to implant failure by reporting conclusions of several
studies showing that smoking is associated with higher failure rates, complications and altered
peri-implant tissue conditions.54,87, 88,149,170 A literature review by Klokkevold and Han (2007)113
suggested that tobacco smoking may be a signiﬁcant risk factor with an adverse effect on implant
survival and success rates in areas of lower jawbone quality but may not be as signiﬁcant in sites
with better bone. While a review by Levin and Schwartz-Arad (2005)49 revealed a signiﬁcant
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association between smoking, peri-implant marginal bone loss, reduced survival rate of implants
(0.001 < p < 0.05) and the outcome of onlay bone grafts (p < 0.05) as well. In a recent metaanalysis (Chen et al 2013),78 smoking was associated with an increased risk of dental implant
failure. However, the analysis did not investigate the effects of tobacco smoking on peri-implant
MBL. Results from another meta-analysis (Chrcanovic et al. 2015),60 suggested that insertion of
dental implants in smokers affected implant failure rates, the risk of postoperative infection, and
peri-implant MBL. It is hypothesized that the increased implant failure rates in tobacco smokers
are mainly due to smoking effect on osteogenesis and angiogenesis. The commercially available
titanium used in dental implant manufacturing have a wide range of surface topographies or
morphologies and chemical and physical properties depending on how it is prepared and
handled, examples include turned, acid-etched, sandblasted and acid-etched, sandblasted and
ﬂuoride-modiﬁed, and oxidized dental implants.56,57,58 It is known that the surface modifications
of different dental implant brands influence the osseointegration process.168 A retrospective
cohort study by Balshe and colleagues (2008)27 reported that smoking was not signiﬁcantly
associated with implant failure among the moderately rough surface (anodized) implants, while it
was associated with implant failure among the group with minimally rough surface implants.
Despite the large number of implants in this study (n = 4607), the results were not included in the
upcoming meta-analysis because the number of placed and the number of failed implants were
not separately reported between smokers and non-smokers. The evidence presented by Balshe et
al.27 did not meet all requirements to be included in the current meta-analysis, however it is a
valuable addition to the literature due to the great number of implants investigated. In a more
recent study by Sayardoust et al. (2013),16 turned implants had more peri-implant MBL and a
higher incidence of failure in smokers, while oxidized implants showed similar MBL and failure
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rates in smokers and non-smokers. Such contrasting results indicate that controversy still exists
and that there is a need for additional studies to investigate the long-term outcomes of implants
with altered surface characteristics in tobacco smokers.113 The studies included in the current
analysis used implants with several different brands and surface characteristics. In a retrospective
study investigating success rates of dental implants placed in grafted maxillary sinuses, Kan et al.
(1999)108 reported a 93.04% success rate in non-smokers and an 82.82% in smokers. In another
study by the same authors175 with a longer follow-up period, the success rate for the non-smokers
was 82.7% and for smokers was 65.3%. Therefore, in considering the difference in success rates
in smokers and non-smokers for implants placed in loose trabecular bone sites that are followed
over a longer period of time, the adverse effect of smoking may become more evident. A longer
follow-up period can lead to an increase in the failure rate, particularly if it extended beyond
functional loading, because other restorative factors can inﬂuence implant failure after loading.
This may project an underestimation of actual failures in some clinical studies. However, it is
difficult to deﬁne what would be considered a short follow-up period to evaluate implant failure
rate in smokers. Results from the meta-analysis by Chrcanovic et al. (2015)60 demonstrated that
smoking is associated with increased number of dental implant failures regardless of the type of
implant surface topography or modification. Additionally, a higher risk ratio was observed with
rough-surface implants compared to turned implants in the smoking group. Nevertheless, there is
some contradictory evidence that smoking is associated with older turned implant surfaces but
not with modern ones. With regard to the bone-implant interface, the detrimental effects of
tobacco smoke have a series of local and systemic influences on bone metabolism.135 Concerning
associations with patients’ tobacco smoking status, peri-implant bone level is known to be
associated with implant prognosis.61,74,82,143,148,149 The peri-implant marginal bone around the
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implant platform is normally a signiﬁcant indicator for deﬁning good peri-implant health. Misch
et al. (2008)48 classiﬁed the implants with marginal bone loss of <2 mm from the time of initial
surgery as successful, while according to Albrektsson and Isidor (1993)62 an implant is regarded
as successful when it presents bone resorption of less than 1.5 mm in the ﬁrst year after
prosthetic loading and 0.2 mm in subsequent years. Other authors 147 have proposed that an
implant should present a lower bone resorption than one third of the implant length, regardless of
the number of years in function. To date, there is no consensus regarding the quantity of periimplant marginal bone resorption consistent with time after placement, overall health, and
success. In a recent meta-analysis by Alfadda (2018),33 smokers experienced significantly more
implant failure and peri-implant marginal bone loss relative to nonsmokers. These findings are in
accordance with those of another review conducted by Moraschini et al. (2016).35 The greater
difference in MBL observed between smokers and nonsmokers in association with aging (~0.02
mm/year) may be explained by a combination of the depleting effect of the tobacco chemicals on
bone vascularity and the slow, progressive, age-related phase of bone loss in trabecular and
cortical bone.97,111,141 A meta-analysis by Strietzel et al. (2007)156 on studies in which threaded
titanium implants with machined, titanium plasma sprayed (TPS) or Hydroxyapatite (HA)-coated
surfaces were predominantly used, revealed a signiﬁcantly enhanced risk for implant failure
among smokers compared to non-smokers. The study compared the implant related odds ratios
for implant failure in smokers considering different observation periods. The risk of implant
failure for smokers ranged from 2.8 after up to 1 year decreasing to about 2.3 up to 5 years,
indicating a higher risk of early implant failure. However, the risk of implant failures in smokers
was found to be signiﬁcantly increased even after 5 years. In an earlier review by Esposito et al.
(1998)87,88 on studies mainly reporting on threaded implants with a machined surface, i.e.
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Branemark implants, the consensus was that smoking has a negative inﬂuence on implant
survival. Furthermore, a comparison between threaded implants with machined and anodicoxidized surfaces showed no signiﬁcant inﬂuence of smoking on implant failures for implants
with an anodic-oxidized surface.142 However, it is probably worth noting that studies including
more modern implants with micro-structured surfaces like sand blasted and/or acid etched
surfaces were scarcely published at that time. In the author’s opinion, whether these implant
surfaces indeed signiﬁcantly improve outcomes in smokers need to be further explored through
studies with larger sample sizes reporting data on implant failure rates in relation to smokers and
non-smokers. The ﬁndings reported by Strietzel et al. (2007)156 considering the implant-related
ORs for implant failures in smokers were remarkably similar to those published in another study
by Hinode et al. (2006)42 who performed a meta-analysis on the effect of smoking on
osseointegrated dental implants, based on implant-related data. This review used a subgroup
analysis to examine success in the maxilla versus the mandible. Whereas the overall OR for
implant failure was 2.17 (95% CI, 1.67–2.83), the OR in the maxilla was 2.06 (95% CI, 1.61–
2.65) and in the mandible was 1.32 (95% CI, 0.72–2.40), meaning the odds of failure was double
in the maxilla, but statistically insignificant in the mandible. These two systematic reviews
represent a small but growing body of evidence indicating implant failure risk is higher in
smokers than in nonsmokers, particularly in the maxilla. In a systematic review by Berglundh et
al. (2002)73 analyzing longitudinal studies of up to 5 years, implant survival rate of 97.5% up to
the second stage surgery was observed. In the same year, Davarpanah et al.85 reported a survival
rate of 96.5% for 1583 implants placed in different regions of the maxilla and mandible, with a
follow-up period of 5 years as well. These results demonstrated a reduction in dental implant
survival rate over time during the follow-up period. Simonis et al. (2010)153 and Carlsson et al.
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(2000)76 concluded that there was a larger number of implant losses and higher level of periimplant marginal bone loss in patients who were smokers. These conclusions are supported by
numerous other studies that have analyzed the inﬂuence of tobacco smoking on the survival and
success of dental implants.6,113,165 A systematic review by Moraschini et al. (2015)34 revealed a
mean survival rate of 94.6% (SD 5.97%) for a total of 7711 implants, with a mean follow-up of
13.4 years. A number of authors from the included studies concluded that bone resorption
occurred and was more evident after the ﬁrst year of prosthetic loading, and in one study (Pikner
et al. 2009)136 it was suggested that implants placed in the mandibular arch tend to present greater
marginal bone resorption over the course of time. This review (Moraschini et al. 2015),34 based
on the results of the included studies, presented a mean peri-implant marginal bone loss of 1.3
mm (SD 0.84 mm), and the study that presented the highest mean bone resorption value of 2.67
mm evaluated 316 implants under mandibular overdentures during 12 years of follow-up (van
Steenberghe et al. 2001).163 The results of pertinent studies should be interpreted with caution
due to the possible presence of uncontrolled confounding factors and the risk of bias. However,
the overall results of most of the recently published studies suggest that placement of dental
implants in smokers affects MBL, the incidence of postoperative complications, as well as
implant failure rates. In light of the findings of this review, smoking may be associated with
significantly increased peri-implant MBL and implant failure rate. Exploring various preventive
and interventional measures that can possibly limit the adverse effect of tobacco smoking on
implant-related outcomes is highly recommended. Additionally, the potential adverse effects of
smoking on treatment outcomes must be explained to the patient before treatment, and the
dentists’ clinical decisions should be specific to each case. As the risk of implant failure is
generally low, individual practitioners will have to decide what modifications to therapy, if any,
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should be employed with their patients. In conclusion, smoking is a signiﬁcant risk factor for
dental implant therapy. This should be clearly conveyed to the patient before treatment. A strict
recall program throughout the course of the treatment to early detect negative changes in periimplant tissues or implant failure is necessary.
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Background
According to the 9th edition of the Glossary of Prosthodontic Terms,95 edentulism is defined as
the state of being edentulous, i.e. without natural teeth. It is estimated that 178 million
Americans are missing at least one tooth & about 40 million are completely edentulous (ACP). 176
The etiology of tooth loss is highly variable, ranging from tooth loss due to dental caries,
periodontal disease, trauma or congenital anomalies. Tobacco smoking is a widely spread habit
practiced all around the world. In 2016, an estimated 15.5% (37.8 million) of U.S. adults were
current cigarette smokers. Of these, 76.1% smoked every day.44 Tobacco smoking is related to
many health risks. It affects general and oral health causing increased risk of periodontal disease,
dental caries, oral neoplasms and delayed wound healing. It was reported that there is an
association between cigarette smoking and dental implant failure.3 The adverse effects of
smoking and nicotine on oral soft tissue have also been observed in less-successful regenerative
procedures and more gingival recession.138 Higher plaque index (PI) and increased probing depth
(PD) have been reported in smokers compared to non-smokers.25 Furthermore, a 5-year
retrospective study comparing different dental implants revealed that smokers have more
marginal bone loss (MBL) around implants than non-smokers.16

Description of the intervention
The endosteal dental implant: a device placed into the alveolar and/or basal bone of the mandible
or maxilla and transecting only one cortical plate.95 It is the most widely used dental implant type
in contemporary dentistry. It is composed of an anchorage component, termed the fixture, which,
ideally, is within the bone, a retentive component, termed the abutment and a restorative
component in the form of a fixed, removable, or fixed-removable implant supported restoration
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replacing single or multiple missing teeth and/or associated tissues. Dental implant survival
refers to a dental implant that reside in placement site in the dental arch at the time of evaluation,
regardless of any disease signs, symptoms, or history of problems. Dental implant success is
usually defined by a set of criteria evaluating the condition and function of the implant at the
time of evaluation, i.e. whether or not the implant satisfies the functional & esthetic demands.
Dental implant failure often refers to loss of osseointegration and implant mobility that warrants
removal of the implant.

How this intervention might work
Brånemark’s pioneering work on the phenomenon of osseointegration revolutionized the dental
implants practice. Osseointegration is the concept that made dental implant therapy possible. It is
defined as the direct structural and functional bone-to-implant contact. Successful
osseointegration involves a series of biological events that includes inflammation, bone
formation and remodeling.90 Missing tooth/teeth replacement with dental implants represents an
invaluable treatment modality in modern dentistry and can preserve healthy natural teeth
structure in cases of partial edentulism.

Why it is important to do this review
Although dental implant therapy is considered a predictable treatment modality with reported
high survival and success rates, biological complications do occur and a number of risk factors
have been involved, including the patient’s medical history, smoking habits, jawbone quality,
radiation therapy, parafunctional habits, surgeon’s experience and susceptibility to periodontitis.
The underlying mechanisms of the detrimental effects of smoking have been studied in vitro and
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in vivo in animal and human studies. In vitro studies indicated that nicotine, a component in
tobacco smoke, has a negative effect on the osteogenic gene expression in osteoblast cell lines.145
Furthermore, nicotine combined with bacterial lipopolysaccharide (LPS) has been shown to
stimulate the formation of osteoclast-like cells.157 Animal experiments have demonstrated that
nicotine attenuates the expression of a wide range of factors involved in the osteogenic
differentiation and formation of extracellular matrix and blood vessels.171 Additionally, smoking
reduces the vascularization of the gingival tissues, impedes the immune response, and promotes
a more pathogenic or “dysbiotic” oral microflora.112 Although the available evidence highlights
the potential biological components affected by smoking, the exact mechanism behind the
greater marginal bone loss (MBL) and the higher incidence of implant failure in smokers are not
fully understood & need further investigation. Although not an absolute contraindication per se,
smoking is considered a risk factor for dental implant failure. Several recommendations were
suggested to enhance implant survival in smokers.45 However, despite the plethora of the current
available literature, confounding factors and inconsistency in reported outcome measures &
implant success criteria is not uncommon.

Objectives
The aim of this systematic review and meta-analysis is to test the null hypothesis of no difference
in dental implant failure rates and marginal bone loss between smokers and non-smokers with
regards to follow-up time.
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Materials and methods
The methodology of this review was adapted from the PRISMA statement (Preferred Reporting
Items for Systematic Reviews and Meta-Analyses).118 The focus question was stated and
categorized according to the PICO format (Population, Intervention, Comparison, and Outcome).
Criteria for considering studies for this review
This review sought prospective and retrospective cohort studies, as well as randomized & nonrandomized clinical trials that compared implant failure rates and peri-implant marginal bone
loss between smokers and non-smokers. In this review, implant failure was regarded as the total
loss of the implant. Only studies published in English were eligible for inclusion.
Types of participants
Study participants are adult subjects, with a minimum age of eighteen years or older, that are
tobacco smokers and non-smokers who are fully or partially edentulous and received dental
implant(s) re-habilitation to overcome problems with conventional removable complete or partial
dentures or for providing alternative treatment options for fixed or fixed-removable implantsupported restorations.
Types of intervention
Surgical placement of a single or multiple titanium endosseous dental implant(s) in one or both
jaws to replace a single missing tooth or multiple missing teeth.
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Types of outcome measures
The outcome measures investigated in this review are the number of failed implants, comprising
the dichotomous or binary outcome variable, and the amount of peri-implant marginal bone loss,
as a continuous outcome variable, in smokers & non-smokers.
Exclusion criteria:
Letters to the editor, animal studies, in vitro studies, case series, case reports, commentaries and
reviews were all excluded. In addition, articles that did not separately report outcome measures
for smokers and non-smokers, included patients with congenital/familial medical conditions or
uncontrolled autoimmune or systemic diseases or unbalanced metabolic disorders, included
subjects with periodontal disease without prior treatment, or were poorly controlled for
confounding variables were excluded. Lastly, any studies that did not obtain ethical approval or
written informed consent, included fewer than 10 patients in each group, used short (<6 mm) or
zygomatic implants or were not available online were also excluded.
Search methods for identification of studies
Electronic searches
An extensive online search of the following databases was performed to locate relevant articles
published up to June 2019: PubMed, Scopus, EBSCOhost Dentistry and Oral Sciences Source.
To identify studies eligible for inclusion in this review, detailed search strategies were developed
for each of the searched databases. These search terms were based on the search strategy
originally developed for Medline (OVID) but revised appropriately for each database in an
attempt to maximize the efficiency and effectiveness of the search and increase the number of
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results. The search strategies incorporated a combination of MeSH (Medical Subject Heading)
terms, controlled vocabulary and free text terms. The search strategies for each database are
listed in Table 4.
Searching other resources
Citations and cross-referencing were comprehensively utilized to further the identification of
studies and peer-reviewed dental journals were hand searched for possible related materials. In
addition, grey literature was explored using Google Scholar and OpenGrey, until to June 2019.

PICO question: Does smoking increase implant failure rate and peri-implant marginal bone
loss in smokers compared to non-smokers?
P: tobacco smokers and non-smokers who are fully or partially edentulous
I: surgical placement of a single or multiple titanium endosseous dental implant(s) in one or both
jaws to replace a single tooth or multiple missing teeth.
C: comparison of outcome measures between smokers and non-smokers
O: outcome measures of implant failure rate and the extent of peri-implant marginal bone loss
Critical appraisal & assessment of risk of bias in the included studies
The Cochrane collaboration's tool for assessing Risk of Bias (RoB) in randomized trials was
utilized to assess randomized clinical trials.100 Quality assessment for non-randomized studies
(prospective and retrospective cohort studies) was performed using the Newcastle–Ottawa scale
(NOS).63 For the categories of ‘selection’ and ‘outcome’, studies may obtain a star/point for each
item. For the ‘comparability’ category, two stars/points may be awarded. The highest score that
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could be assigned to a study according to the NOS was nine stars/points (highest scientiﬁc
evidence). Studies scoring six stars/points and above were considered to be of high quality.
Data extraction
Customized data extraction sheet were formulated and the following data were extracted from
the included studies (when available): author(s) name(s), publication year, study type, follow-up
period, number, gender and age of the subjects, smoking status & description, number & location
of implants placed, implant brand, surface characterization, size & dimensions, healing period
before loading, marginal bone loss in millimeters +/- standard deviation (SD), implant survival
rate, number of failed and placed implants in smokers & non-smokers, P-value for implant
failure rate, and the number of drop-outs.

Dealing with missing data
The original investigators were contacted by e-mail in cases of missing or unreported data.

Statistical analysis
Dichotomous and continuous variables from the included studies were analyzed through metaanalysis when the same type of data was assessed by at least two studies. For binary outcomes,
i.e. implant failure, the estimate of the intervention effect was expressed in the form of odds ratio
(OR) with a conﬁdence interval (CI) of 95%. For continuous outcomes, i.e. marginal bone loss,
the average and standard deviation (SD) were used to calculate the standardized mean difference
(SMD) with a 95% CI. The results were pooled using the ﬁxed-effects model (Mantel–Haenszel–Peto test) or random-effects model (DerSimonian–Laird test).
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Assessment of heterogeneity
The I2 statistical test was used to express the percentage of heterogeneity in the studies. Values
up to 25% were classiﬁed as indicating low heterogeneity, values of 50% as indicating medium
heterogeneity, and values of ≥ 70% as indicating high heterogeneity. The results of the randomeffects model were validated when signiﬁcant heterogeneity was observed (P < 0.10). The ﬁxedeffects model was considered when low heterogeneity was observed. The level of statistical
signiﬁcance was set at P < 0.05. All data were analyzed using the Review Manager software;
version 5.2.8 (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen,
Denmark; 2014).

Publication bias
Publication bias was explored graphically through a funnel plot. Asymmetry in the funnel plot
may indicate possible publication bias.

Results
Literature search
The electronic search yielded 379 titles from the selected databases. Additional 22 relevant
articles were identified through other resources. After removal of duplicates, the records were
screened by reading the title & abstract (& data tables when available). 30 articles were selected
for full-text review. Seven studies were excluded (Table 3) after careful analysis, as they did not
conform to the eligibility criteria of this review. Therefore, 23 studies; 3 RCTs and 20
observational cohort studies published between 1993 and 2018 were included in the meta-
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analysis. The data search and selection process of studies are presented in Figure 1 as a
PRISMA flow diagram.

Fig 1: PRISMA flow diagram of the screening and article selection process.
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Characteristics of the included studies
Eight prospective and twelve retrospective cohort studies and three randomized clinical trials
were included. The number of participants in the studies ranged from 32 to 1727 subjects, and
the age range was 17 to 88 years. The follow-up period ranged from 6 to 240 months. The
number of implants installed in smokers was 7124 and in non-smokers was 19226. The
Branemark system (Nobel Biocare) was the most commonly used implant system. Five studies
provided definitions for the smoking habits of the participants in terms of quantity or number of
years of smoking, while only two studies did not provide definitions for the smoking habits of
the patients investigated. Eleven studies reported a statistically signiﬁcant difference in the
average number of implant failures between smokers and non-smokers. The difference was not
statistically signiﬁcant in only one study. The characteristics of the included studies are presented
in Table 1.

Quality assessment
The Cochrane RoB tool scores for corresponding randomized controlled trials were included in
the forest plot (Figure 2) for the 3 included RCTs. For observational studies, only four studies
obtained a score of less than six stars on the NOS. The scores for each study are summarized in
Table 2.

Marginal bone loss
14 out of the 23 included studies reported on the analysis of marginal bone loss. All studies
performed this analysis via standardized radiographic measurements from the implant platform
to the alveolar bone crest. The marginal bone loss in the group of smokers ranged from 0.07 to
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4.65 mm, while in the non-smoking group the marginal bone loss ranged from 0.04 to 3.13 mm.
The analysis of marginal bone loss was performed using the random-effects model because of
the high level of heterogeneity (I2 = 98%; P < 0.00001). A standardized mean difference (SMD)
of 1.07 (95% CI 0.67–1.48) was found, demonstrating a statistically signiﬁcant difference in
favor of non-smokers (P<0.00001). Four studies analyzed the marginal bone loss between
maxillary and mandibular implants in smokers. Despite the high level of heterogeneity (I2 =
97%; P = 0.00001), a SMD of 1.39 (95% CI 0.35–2.42) were observed, yielding a statistically
signiﬁcant difference in favor of the mandible (P < 0.008). Figure 2 shows Forest plots for
marginal bone loss in smokers compared to non-smokers and for MBL in maxilla versus
mandible in the smokers’ group.

Implant failure rate
Thirteen studies reported on the number of implant failures in smokers versus non-smokers. The
average survival rate of implants varied from 84.2% to 97% in the group of smokers, and from
95.2% to 98.8% in the group of non-smokers. The results of the analysis of implant failure were
classiﬁed into two subgroups according to the follow-up time, i.e. <5 years & >= 5 years. The
ﬁxed-effects model was used for this analysis because of low heterogeneity (I2 = 34%; P <
0.11). The total odds ratio was 2.24 (95% CI 1.90–2.64), demonstrating a statistically signiﬁcant
difference in favor of the non-smoking group (P < 0.00001). The results for follow up subgroups
differences demonstrated a signiﬁcant increase in implant failure with the increase in follow-up
time (P = 0.05) although with considerable heterogeneity (I2=74.5%). The overall odds ratio for
implant failure rate and the ORs for the subgroup analysis are shown in Figure 3.
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Publication bias: Analysis of implant failure revealed symmetry of the funnel plot, therefore
rejecting the possibility of publication bias (Figure 4).

Discussion
Tobacco smoking is an accepted potential risk factor for general and oral health. Investigating
the causes of peri-implant marginal bone loss and implant failure is important for predictable
implant therapy. Cigarette smoking has different adverse local and systemic effects. Local effects
are mainly due to nicotine and cytotoxic vasoactive substances generated in the combustion of
tobacco smoke. Systemically, cigarette smoking negatively affects the cellular immunologic
response of neutrophils and production of antibodies. Smoking also influences bone metabolism
and turn-over. If local absorption of cigarette smoke products had a definite influence on the
failure of implants, this may explain the lower rates of mandibular implant failure in smokers as
this area is possibly protected by the tongue and more salivary flow. Several clinical studies have
shown that the survival of implants can be affected by tobacco smoking. The smoking habits
assessed in this review are based on the patients' acknowledgment in the included studies.
However, the quantity and frequency of smoking can be a key factor in determining the
predictability of success in dental implants treatment. Only ﬁve studies included in this review
deﬁned or classiﬁed smokers, this is a critical factor for risk assessment, but it’s often overlooked
or under-reported. In a meta-analysis, homogeneity implies a mathematical compatibility
between the results of each individual trial. Potential biases are likely to be greater for nonrandomized studies compared with RCTs, so results should always be interpreted with caution
when they are included in reviews and meta-analyses. However, narrowing the inclusion criteria
increases homogeneity but also excludes the results of more trials, and thus risks the exclusion of
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signiﬁcant data.152 This was the reason to include non-randomized studies in the present metaanalysis. This issue is important because meta-analyses are frequently conducted on a limited
number of RCTs. In meta-analyses, such as these, adding more information from observational
studies may aid in clinical reasoning and establish a more solid foundation for causal inferences.
In the present meta-analysis, the statistical unit of analysis for ‘implant failure’ was the implant.
It would be technically more correct to adjust for the effect of clustered, correlated observations;
however, it is a challenging analytic method and the implant survival is so high that failing to
adjust for clustered, correlated observations would have little effect on the estimate and deviation
of survival.79 This systematic review attempted to identify studies comparing the marginal bone
loss and implant failure rate between smokers and non-smokers. The search produced
observational prospective and retrospective cohort studies and clinical trials. Despite the
relatively small number of randomized controlled trials included, the inclusion of a large number
of longitudinal observational studies, with large number of participants through a well-defined
inclusion and exclusion criteria, in the meta-analysis can potentially increase the amount of
information and consolidate the results from the clinical studies. Five different definitions in
relation to smoking were reported by the studies, i.e. smoker and non-smoker, smoker and never
smoker, low consumption and high consumption, mild smokers and heavy smoker, and one study
defined smokers as individuals who smoked half a pack or more of cigarettes a day. The contrast
in descriptions and definitions highlights these differences as potential confounding variable.
Currently, there is no standardization in the classiﬁcation of patients regarding the number of
cigarettes smoked per day. In addition, other confounding risk factors are known to inﬂuence the
results by generating publication bias. There is still no consensus in the current evidence
regarding the procedures that can minimize the risk of smoking on the health of dental implants.
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Two-stage implant placement may decrease the physical contact with tobacco smoke and prevent
the accumulation of bacterial bioﬁlms on the implant platform during the healing period, as it is
already known that smoking patients tend to have greater bacterial bioﬁlm adhesion. Also,
improving the gingival phenotype (increasing the area of keratinized mucosa) in the areas
adjacent to implant sites would be a prudent measure. Because tobacco smoking can affect
immune function, periodontally susceptible patients may be at a higher risk for dental implant
complications, like increased amount of marginal bone loss and implant failure rates. However, a
recent meta-analysis that evaluated the interaction between smoking and peri-implantitis
concluded that there is low evidence implicating smoking as a risk factor for the development of
peri-implant disease.150 There is a growing evidence in the literature indicating that tobacco
smoke ingredients, as nicotine, may delay or inhibit healing after oral surgical procedures. The
most accepted theory for the inﬂuence of smoking on healing in the oral tissues is the decrease in
local blood ﬂow resulting from vasoconstriction, which causes changes in the cell population and
the inﬂammatory process. Results of the present meta-analysis revealed that the marginal bone
loss was signiﬁcantly higher in smokers compared to non-smokers (P < 0.00001). A comparison
of the maxillary & mandibular arches revealed a significant difference favoring implants placed
in the mandible. (P < 0.008). It is believed that the maxilla is more permeable to the effects of
tobacco smoke possibly due to its increased medullary bone content and vascularity compared to
the mandible. The bacterial plaque tends to adhere more quickly on the epithelial cells of
smokers. This may cause an increase in the incidence of biological complications, such as periimplant mucositis and peri-implantitis and consequently an increase in the rate of peri-implant
marginal bone loss. Limited number of clinical studies have compared implant marginal bone
loss between smokers and non-smokers. Bain and Moy (1993)3 proposed that tobacco smoking
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and decreased quality of available jawbone, could negatively affect healing and increase
marginal bone loss, mainly in the maxillary arch. The current review analysis results for implant
failure rate showed signiﬁcant increase in failure rate in smokers compared to non-smokers (P <
0.00001). Additionally, the follow-up subgroups comparison revealed that implant failure rate
increased with the increase in follow-up time (P = 0.05). However, considerable heterogeneity
(I2=74.5%) was observed.

Suggestions for future research
A larger number of high-quality longitudinal studies, preferably be RCTs, with a follow-up
period of at least 5 years evaluating the clinical performance of implants with emphasis on
reporting outcomes for smokers and non-smokers individually, and possibly including implants
with various surface characterizations and/or modifications, should be conducted in accordance
with the guidelines available in the Consolidated Standards of Reporting Trials (CONSORT)
statements.128 There should be standardization of the success criteria, thereby facilitating
communication and comparison of the reported data. Aesthetics is a fundamental factor in dental
implant therapy. In spite of this, no success criteria adopted by the studies in this review touched
on the individual aesthetic criteria, such as the angle and positioning of the implants and the
natural profile of peri-implant soft tissues. Aesthetic outcomes must be part of the evaluation of
implant success. Lastly, with the growing popularity of electronic cigarettes and other similar
devices, it might be worth-while looking into data generated by evaluation of dental implants
placed in individuals who use these devices.
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Conclusion
In light of the results of this review, tobacco smokers have a higher risk of biological dental
implant complications compared to non-smokers. A statistically signiﬁcant difference (P <
0.00001) in peri-implant marginal bone loss was found between the smoking group and the nonsmoking group, in favor of the non-smoking group with a standardized mean difference (SMD)
of 1.07 (95% CI 0.67–1.48). Marginal bone loss in smokers was increased in the maxilla
compared to the mandible with a SMD of 1.39 (95% CI 0.35–2.42) revealing a statistically
signiﬁcant difference in favor of the mandible (P < 0.008). The total odds ratio for implant
failure rate was 2.24 (95% CI 1.9–2.64), demonstrating a statistically signiﬁcant difference in
favor of non-smokers (P < 0.00001). The results for follow up subgroups differences
demonstrated a signiﬁcant increase in implant failure with the increase in follow-up time (P =
0.05) although with considerable heterogeneity (I2=74.5%). Therefore, tobacco smoking patients
must be encouraged to quit smoking or at least decrease consumption. Although causality
between the measured parameters cannot be assessed with absolute certainty in observational
studies, the outcomes of the current investigation indicate that there is a connection between
tobacco smoking and increased peri-implant marginal bone loss and implant failure. So, for
patients who actively smoke, as in other periodontal & oral surgical procedures, the clinical
recommendation for a period of abstinence that at least covers the pre-surgical evaluation, initial
therapy, definite implant treatment & immediate post-op phases remain to be very relevant.
Therefore, taking into consideration the disparate outcome measures employed to assess dental
implant performance and within the limitations of this systematic review, the null hypothesis is
rejected, and the alternative hypothesis is accepted, which is in agreement with other related
meta-analyses reported elsewhere in the literature.
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Table 1: characteristics of included studies

Author &
year of
publication

Study type
Follow-up
period in
months
(mean or
range)

No. of
subjects
No. per
group

Bain 1993

Retrospective
72

540
NR

Haas 1996

Retrospective
Up to 108

421
S:107
NS:314

Retrospective
120

45
S:21
NS: 24

Lindquist
1997

Age
range
Mean
age
Gender
13–85
55.1
229
M/311
F
16–88
53.1
171
M/250
F
(33-64)
M: 13
F: 32

Kumar 2002

Prospective
18

461
S:72
NS: 389

NR
NR
NR

SchwartzArad 2002

Prospective
36

261
S:89
NS: 172

18–67
48
NR

RCT

52
S: 17
NS: 34

NR
59.5
NR

Wennstrom
2004

Smoking
definition

Number
of
implants
&
location

Implant
brand
&
Surface

Smoker and
non-smoker

2194

Branemark
Machined

1366

Branemark,
Friatec
Machined,
rough

Smoker and
non-Smoker

Smoker and
non-smoker
Smoker
consisted of
patients who
smoked half a
pack or more
cigarettes a
day
Non-smokers;
mild smokers
(upto10
cigarettes/day);
heavy smokers
(>10
cigarettes/ day)
Smoker and
non-smoker

Implant
dimensions

Healing
Period for
loading
(months)

Marginal
bone loss
(mm)
(mean +/SD)

Implant
survival
rate
(%)

Failed/placed
implants
in each
group

P-value
(for
implant
failure
rate)

Dropouts

NR x 7,10,
13,15,18,20

6(maxilla)
3(mandible)

NR

S:88.7
NS:95.2

S:44/390
NS:86/1804

<0.001

NR

3 to 7

S:2.7 +/1.87
NS:1.58
+/- 1.42

NR

NR/366
NR/1000

NR

NR

NR

S:NR/125
NS:2/139

<0.001

1

NR

266

Branemark

NRx10

4

S: 1.3+/0.55
NS:0.65+/0.2

1183

Straumann
Rough

NR

1 to 3

NR

S:97
NS:98.3

S:8/269
NS:15/914

<0.05

NR

959

NR
NR

NR

NR

NR

S:96
NS:98

S:15/380
NS: 12/579

<0.05

NR

149
S: NR
NS: NR

Astra Tech
(screwshaped,selftapping)

NR

S: 0.41 +/0.69
NS: 0.30
+/- 0.84

97.3
S: NR
NS: NR

NR/50
NR/99

NR

NR
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GalindoMoreno
2005

Prospective

185
S: 63
NS: 122

NR
49.77
NR

Smoker and
non-smoker

514
S: NR
NS: NR

148pressfit, 366
screw type

Non-smokers;
mild smokers
(upto10
cigarettes/day);
heavy smokers
(>10
cigarettes/ day)

646

NR
NR

1330
S: 285
NS:
1045

Branemark

Branemark
Machined

NR

NR

S: 0.45 +/0.18
NS: 0.42
+/- 0.12

NR
S: NR
NS: NR

S: 175
NS: 339

NR

NR

NR

S:0.15 +/0.09
NS: 0.04
+/- 0.04

NR
NR

S:NR/271
NS:NR/375

NR

NR

S: NR
NS: NR

95.79
S:
94.74
NS:
96.94

S: 26/285
NS: 32/1045

NR

NR

NR
NR

NR/494
NR/1045

NR

NR

95.5
S: 91
NS:
96.15

S: 5/56
NS: 4/104

NR

NR

S:84.2
NS:98.6

S:15/95
NS:1/70

<0.001

NR

Prospective
9.4-86.6
(mean 45.5)

161
S:59
NS: 102

23–89
57
NR

DeLuca
2006

Prospective
cohort

389
S: 285
NS: 104

NR
49.3
NR

Smoker and
non-smoker

DeLuca &
Zarb 2006

Prospective
Up to 240

200
S:54
S:146

15–77
52.1
NR

Smoker and
non-smoker

1539

Herzberg
2006

Prospective
cohort
56.5

60
S: 21
NS: 39

NR
52
NR

Smoker and
non-Smoker

212
S: NR
NS: NR

Screw type

66
S:40
NS:26

15–71
43.4
NR

165

Biotech
Rough

NR

NR

S:2.41 +/1.46
NS:3.13
+/- 1.59

650
S:76
S: 574
475
S:63

13–84
42.7
NR
51.96+/11.98

Non-smokers;
light smokers
(<10
cigarettes/
day); moderate
smokers (10–
20
cigarettes/day);
heavy smokers
(>20
cigarettes/day)
Smoker and
non-smoker

1628

NR

NR

NR

NR

S:96.6
NS:97.1

S:7/197
NS:43/1431

0.5994

NR

NR

1626
NR

NR

NR

NR

NR

NR

S: 21/226
NS: 56/1400

0.0006

17

Nitzan 2005

SanchezPerez 2007

Retrospective
60

Sverzut
2008

Retrospective
8

Anner 2010

Retrospective
1-114

NR

35

NR

NR

NR

6(maxilla)
3(mandible)

NR

NR

S:0.07 +/0.26
NS:0.04
+/-0.12
S: 0.24 +/0.49
NS: 0.09
+/- 0.32
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NS:412

Cavalcanti
2011

RodriguezArgueta
2011

M:176
F: 299

Retrospective
60

1727
S:549
NS:1178

17–85
49.2
M:702
F:1025

Smoker and
non-smoker

5843

Retrospective
6 minmum

295
S:113
NS: 182

21-68
53.1+/12.5
M:127
F: 168

NR

1033

Vandeweghe
2011

Retrospective
60

Stoker 2012

RCT
99.6

Vervaeke
2012

Retrospective
24

Sayardoust
2013

Retrospective
60

18–84
54
M:141
F:188

Smoker and
non-smoker

59.8
M: 28
F: 66

Smoker &
never smoker

300
S:65
NS:235

17–82
56
M:114
F:186

Smoker and
non-smoker

80
S: 40
NS:40

NR 57.6
M:38 M
F:42

Smoker and
non-smoker

329
S:41
NS:288
94
S: 35
NS:59

3i,
AstraTech,
Camlog,
FriadentDentsply,
Nobel
Biocare,
Straumann,
Sweden and
Martina,
Zimmer
Rough
Nobel
Biocare
Impladent
Astratech
(Rough
surface)

NR

0-9

NR

S:94.5
NS:97.1

S:107/1961
NS:112/3882

0.003

250

NR

NR

NR

NR

S: 14/389
NS: 18/644

NR

0

3.5,
3.75,4,4.3,
5, 6x8.5,
10,10.5,
11.5,
12,13,13.5,
15, 16.5,18

NR

S:1.56+/0.53
NS:1.32+/0.38

S:95.2
NS:98.8

S: 5/104
NS: 7/608

0.007

NR

NR

3

96.5%

10/256
S:NR/96
NS:NR/160

NR

16

S:96.7
NS:98.7

S:8/244
NS:11/849

0.025

0

S:89.6
NS:96.9

S:4/40
NS:1/40

<0.05

0

712

Southern
Implants
Rough

256

ITI/Bonefit
dental
implants
TPS

1093

NR
NR

3.5,
4,4.5,5x8,
9,
11,13,15,17

NR

80

Branemark;
Nobel
Biocare
Rough

NR

3 to 4

36

S: 1.72+/1.65
NS:
0.92+/-0.8
S:0.53+/0.92
NS:0.29+/0.54
S: 1.39+/1.57
NS:
1.01+/1.09

Cha 2014

Prospective
cohort

161
S: 18
NS: 143

462
S: 48
NS: 414

Implatinium

NR

4.1x10-14

NR

Smoker and
non-smoker

96
Max:67
Mand:
29

Brånemark,
Nobel
Biocare
Machined,
oxidized, &
lasermodified

177
Max:100
Mand:77

NR
Rough

Sayardoust
2017b

RCT
3

32
S:16
NS:16

61.8
M:17
F: 15

Smokers: an
average of>10
cigarettes/day
for>10 years &
non-smokers

Al-Aali
2018

Retrospective
60

56
S: 29
NS: 27

35-51
45
NR

Smoker &
never smoker

NR

Table 1 cont'd: characteristics of included studies
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NR

NR

96.53
S: 85.42
NS:
97.83

3

S: 2.5+/0.11
NS: 2.1+/0.06

NR

NR

S: 4.65+/0.68
NS: 1.8+/0.33

NR

S: 7/48
NS: 9/414

S: NR/48
NS: NR/48

S:NR/86
NS:NR/91

NR

NR

NR

0

NR

0

Selection

Authors (Years)

Representativ
-eness
of the exposed
cohort

Selection
of the
nonexposed
cohort

Bain (1993)
Haas (1996)
Lindquist (1997)
Kumar (2002)
Schwartz-Arad (2002)
Galindo-Moreno (2005)
Nitzan (2005)
DeLuca (2006)
DeLuca & Zarb (2006)
Herzberg (2006)
Sanchez-Perez (2007)
Sverzut (2008)
Anner (2010)
Cavalcanti (2011)
Rodriguez-Argueta(2011)
Vandeweghe (2011)
Vervaeke (2012)
Sayardoust (2013)
Cha (2014)
Al-Aali (2018)

0
0
*
0
0
*
0
0
0
*
*
0
*
*
0
0
0
0
*
0

*
*
*
*
*
*
*
*
*
0
*
*
0
*
0
*
*
*
*
0

Ascertainment
of exposure

Outcome
of
interest
not
present
at start

Comparability
of cohorts on
the basis of the
design or
analysis

*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*

*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*

*0
*0
*0
*0
*0
*0
*0
*0
*0
*0
**
*0
**
*0
*0
**
**
**
*0
*0

Assessment
of outcome

*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*

Table 2: Newcastle-Ottawa Scale quality assessment for cohort studies
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Outcome
Was
follow-up
long
Adequacy of
enough
follow-up
for
of cohorts
outcomes
to occur?
*
0
*
0
*
0
0
0
*
0
0
0
*
0
*
0
*
0
*
0
*
0
0
0
*
*
*
*
0
*
*
0
*
0
*
0
0
*
0
0

Total
9/9

6/9
6/9
6/9
5/9
6/9
6/9
6/9
6/9
6/9
6/9
8/9
5/9
8/9
8/9
5/9
7/9
7/9
7/9
7/9
4/9
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Figure 2: Forest plots for MBL in smokers vs non-smokers and for MBL
in maxilla vs mandible in smokers. Also, the Cochrane RoB tool
assessment scores for the 3 included RCTs.
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Figure 3: Forest plot for implant failure rate in smokers vs
non-smokers with subgroup analysis for follow up time.

Fig 5: Funnel plot for the studies reporting the outcome measure: implant failure rate.
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Author (year): Title
Aglietta (2010): A 10-year
retrospective analysis of marginal
bone-level changes around
implants in periodontally healthy
and periodontally compromised
tobacco smokers
Al Amri (2017): Comparison of
Peri-Implant Soft Tissue
Parameters and Crestal Bone Loss
Around Immediately Loaded and
Delayed Loaded Implants in
Smokers and Non- Smokers: 5Year Follow-Up Results

Characteristics of excluded studies
Type
Reason for exclusion
Retrospective Did not individually report MBL levels or the total
number of failed/placed implants at the end of the
follow up period and how many were placed in
smokers and non-smokers.

Ata-Ali (2016): Impact of heavy
smoking on the clinical,
microbiological and
immunological parameters of
patients with dental implants: a
prospective cross-sectional study
Balshe (2008): The effects of
smoking on the survival of smooth
and rough surface dental implants
Baqain (2012): Early dental
implant failure: risk factors

Sun (2016): Effect of Heavy
Smoking on Dental Implants
Placed in Male Patients Posterior
Mandibles: A Prospective Clinical
Study
Uribarri (2017): Bone
Remodeling around Implants
Placed in Augmented Sinuses in
Patients with and without History
of Periodontitis

Standard deviation for the mean total CBL (crestal
bone loss) for smokers and non-smokers is not
reported. Though can be estimated through some
calculations, its usually inaccurate and can increase
heterogeneity in the results. The total number of
failed/placed implants at the end of the follow up
Retrospective
period and how many were placed in smokers and
non-smokers are not reported. Attempted to contact
the corresponding author by e-mail but received no
reply.
Did not individually report MBL levels or the
number of failed/placed implants in smokers versus
non-smokers. Microbiological sampling of the periProspective
implant sulcus fluid is the main focus of the study.
Did not individually report MBL levels or the
number of failed/placed implants in smokers versus
Retrospective
non-smokers. The study focused on smooth versus
rough implant surface comparison.
Of the 15/399 failed/placed implants, the study did
not report how many were placed in smokers and
Prospective non-smokers. Attempted to contact the
corresponding author by e-mail but received no
reply.
The distribution of the implants placed (n=45)
among the heavy smokers and non-smokers is not
Prospective reported. Also, the study evaluated only 1 implant
per patient. The osteogenic jaw bone sampling is
the main focus of the study.
The total number of failed/placed implants at the
end of the follow up period and how many were
placed in smokers and non-smokers are not
reported. The MEAN MBL+/- SD in smokers and
Prospective
non-smokers at the end of the follow up period is
not reported. Attempted to contact the
corresponding author by e-mail but received no
reply.

Table 3: excluded studies and reason(s) for exclusion.
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Search strategies
PubMed

Results

(((((((jaw, edentulous[MeSH Terms]) OR jaw, edentulous, partially[MeSH Terms])
OR smoking[MeSH Terms]) OR cigarette smoking[MeSH Terms])) AND ((((((dental
implant[MeSH Terms]) OR dental implants[MeSH Terms]) OR dental
implantation[MeSH Terms]) OR dental implantation, endosseous[MeSH Terms]) OR
endosseous dental implantation[MeSH Terms]) OR osseointegrated dental
implantation[MeSH Terms])) AND ((smokers) OR nonsmokers)) AND ((((((((((((bone
resorption[MeSH Terms]) OR dental implant bone resorption) OR alveolar bone
150
loss[MeSH Terms]) OR marginal bone loss) OR dental implant bone loss) OR
periodontal pocket[MeSH Terms]) OR dental implant probing depth) OR peri-implant
probing depth) OR peri-implant tissue health) OR survival rates[MeSH Terms]) OR
cumulative survival rates[MeSH Terms]) OR dental implant survival)
Scopus
Results
Smoking OR cigarette smoking AND dental implants OR dental implantation OR
endosseous dental implants OR osseointegrated dental implants AND marginal bone
loss OR bone resorption OR dental implant bone resorption or dental implant bone
loss or dental implant probing depth or peri-implant bone loss
EBSCOhost Dentistry & Oral Sciences
Smoking AND dental implant complications OR marginal bone loss OR implant
failure rate
379

40
Results
189
Total

Table 4: the final Boolean search keywords utilized in different electronic databases. Last search
update June 1st, 2019.
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